A new clinical study published in the International Journal of Gynecological Cancer reports encouraging results for women ...
In BREAKWATER, EC plus FOLFIRI achieved a 64.4% response rate and showed a trend toward improved overall survival in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback